Thanigaivelan Kanagasabai
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostatic Neoplasms | 5 | 2024 | 935 | 1.030 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2021 | 10 | 0.810 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2021 | 20 | 0.800 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2019 | 40 | 0.680 |
Why?
|
| Imidazoles | 1 | 2019 | 126 | 0.670 |
Why?
|
| Piperazines | 1 | 2019 | 111 | 0.660 |
Why?
|
| Cell Proliferation | 5 | 2024 | 1198 | 0.640 |
Why?
|
| Angiogenesis Inhibitors | 2 | 2018 | 59 | 0.630 |
Why?
|
| Pyridinium Compounds | 1 | 2017 | 27 | 0.610 |
Why?
|
| Adenocarcinoma | 1 | 2019 | 251 | 0.590 |
Why?
|
| Indoles | 1 | 2017 | 158 | 0.550 |
Why?
|
| MicroRNAs | 1 | 2021 | 426 | 0.540 |
Why?
|
| Cell Movement | 2 | 2024 | 571 | 0.520 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 2 | 2024 | 11 | 0.430 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2024 | 269 | 0.370 |
Why?
|
| Breast Neoplasms | 2 | 2018 | 1502 | 0.350 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 2 | 2018 | 31 | 0.310 |
Why?
|
| Mice | 8 | 2024 | 5913 | 0.310 |
Why?
|
| Neovascularization, Pathologic | 2 | 2018 | 127 | 0.290 |
Why?
|
| Apoptosis | 3 | 2024 | 1398 | 0.270 |
Why?
|
| Signal Transduction | 3 | 2024 | 1908 | 0.260 |
Why?
|
| S-Phase Kinase-Associated Proteins | 1 | 2024 | 16 | 0.240 |
Why?
|
| Breast Neoplasms, Male | 1 | 2024 | 3 | 0.240 |
Why?
|
| Cell Line, Tumor | 5 | 2024 | 2231 | 0.240 |
Why?
|
| Disease Progression | 2 | 2024 | 601 | 0.220 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2023 | 88 | 0.210 |
Why?
|
| Nuclear Proteins | 2 | 2024 | 307 | 0.210 |
Why?
|
| Animals | 8 | 2024 | 15081 | 0.210 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2021 | 9 | 0.200 |
Why?
|
| Repressor Proteins | 2 | 2024 | 249 | 0.200 |
Why?
|
| Melanoma, Experimental | 1 | 2021 | 9 | 0.200 |
Why?
|
| Poly I-C | 1 | 2021 | 7 | 0.200 |
Why?
|
| Withanolides | 1 | 2021 | 9 | 0.200 |
Why?
|
| Mice, Nude | 2 | 2021 | 337 | 0.190 |
Why?
|
| Male | 8 | 2024 | 20025 | 0.190 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2021 | 259 | 0.190 |
Why?
|
| Mitochondria | 1 | 2024 | 487 | 0.180 |
Why?
|
| Immunotherapy | 1 | 2021 | 95 | 0.180 |
Why?
|
| CDC2 Protein Kinase | 1 | 2019 | 17 | 0.180 |
Why?
|
| Biological Products | 1 | 2021 | 71 | 0.180 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2019 | 55 | 0.180 |
Why?
|
| Lung Neoplasms | 1 | 2023 | 358 | 0.170 |
Why?
|
| Humans | 10 | 2024 | 37093 | 0.170 |
Why?
|
| Cell Cycle Proteins | 1 | 2021 | 229 | 0.160 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2021 | 807 | 0.160 |
Why?
|
| Mucin-1 | 1 | 2018 | 9 | 0.160 |
Why?
|
| Small Molecule Libraries | 1 | 2018 | 45 | 0.150 |
Why?
|
| Transcription Factors | 1 | 2021 | 681 | 0.140 |
Why?
|
| Mice, Knockout | 3 | 2024 | 933 | 0.130 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 803 | 0.090 |
Why?
|
| Female | 4 | 2024 | 20969 | 0.080 |
Why?
|
| Receptor, Adenosine A2B | 1 | 2023 | 4 | 0.060 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2023 | 4 | 0.060 |
Why?
|
| Memory Disorders | 1 | 2024 | 73 | 0.060 |
Why?
|
| Phosphates | 1 | 2023 | 51 | 0.060 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2023 | 43 | 0.060 |
Why?
|
| Adenosine | 1 | 2023 | 59 | 0.060 |
Why?
|
| Mitochondrial Proteins | 1 | 2024 | 107 | 0.060 |
Why?
|
| Ubiquitination | 1 | 2023 | 61 | 0.060 |
Why?
|
| Lysosomes | 1 | 2023 | 91 | 0.050 |
Why?
|
| Astrocytes | 1 | 2024 | 255 | 0.050 |
Why?
|
| Interferon Inducers | 1 | 2021 | 2 | 0.050 |
Why?
|
| Incidence | 1 | 2024 | 922 | 0.050 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2021 | 36 | 0.050 |
Why?
|
| Hippocampus | 1 | 2024 | 561 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2024 | 517 | 0.050 |
Why?
|
| Drug Therapy, Combination | 1 | 2021 | 227 | 0.050 |
Why?
|
| Kidney Neoplasms | 1 | 2021 | 68 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 1 | 2021 | 502 | 0.040 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2021 | 110 | 0.040 |
Why?
|
| Inflammation | 1 | 2024 | 618 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 1 | 2024 | 1609 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2021 | 661 | 0.040 |
Why?
|
| Proteoglycans | 1 | 2018 | 47 | 0.040 |
Why?
|
| Laminin | 1 | 2018 | 61 | 0.040 |
Why?
|
| Drug Combinations | 1 | 2018 | 98 | 0.040 |
Why?
|
| Collagen | 1 | 2018 | 172 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2020 | 539 | 0.040 |
Why?
|
| Brain | 1 | 2024 | 1346 | 0.030 |
Why?
|
| Risk Factors | 1 | 2024 | 3562 | 0.030 |
Why?
|